Prophase Labs Stock Investor Sentiment

PRPH Stock  USD 0.37  0.01  2.63%   
Under 56% of ProPhase Labs' investor base is looking to short. The analysis of overall sentiment of trading ProPhase Labs stock suggests that many investors are alarmed at this time. ProPhase Labs' investing sentiment shows overall attitude of investors towards ProPhase Labs.

Comfort Level 44

 Impartial

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use ProPhase Labs' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward ProPhase Labs.

ProPhase Historical Sentiment

Although ProPhase Labs' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding ProPhase, such as negative comments on social media and news outlets, may cause fear in the market and push ProPhase Labs' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of ProPhase.

ProPhase Labs Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards ProPhase Labs can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

ProPhase Labs Historical Investor Sentiment

Investor biases related to ProPhase Labs' public news can be used to forecast risks associated with an investment in ProPhase. The trend in average sentiment can be used to explain how an investor holding ProPhase can time the market purely based on public headlines and social activities around ProPhase Labs. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
ProPhase Labs' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for ProPhase Labs and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average ProPhase Labs news discussions. The higher the estimate score, the more favorable the investor's outlook on ProPhase Labs.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of ProPhase Labs' Stock prices. Below is the latest headlines and news related to ProPhase Labs Stock. The global stock market is bearish. About 67% of major world exchanges and indexes are down. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about ProPhase Labs that are available to investors today. This information is accessible both publicly - through ProPhase Labs' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of ProPhase-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of ProPhase Labs news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ProPhase Labs relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ProPhase Labs' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ProPhase Labs alpha.

ProPhase Largest EPS Surprises

Earnings surprises can significantly impact ProPhase Labs' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2004-10-28
2004-09-300.020.030.0150 
1997-08-13
1997-06-300.080.07-0.0112 
2010-11-10
2010-09-300.090.06-0.0333 
2000-10-26
2000-09-30-0.020.010.03150 
1998-10-30
1998-09-300.230.2-0.0313 
2025-08-13
2025-06-30-0.15-0.110.0426 
View All Earnings Estimates
a day ago at globenewswire.com         
ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of t...
Macroaxis News: globenewswire.com
a day ago at thefly.com         
ProPhase Labs announces publication of BE-Smart Esophageal Cancer study PRPH
news
2 days ago at globenewswire.com         
ProPhase Labs Engages RedChip Companies to Lead Investor Relations Efforts
Macroaxis News: globenewswire.com
2 days ago at thefly.com         
ProPhase Labs engages RedChip to lead investor relations efforts PRPH
news
few days ago at news.google.com         
How strong is ProPhase Labs Inc. stock revenue growth - 2025 EndofYear Setup AI Enhanced Execution A...
Google News at Macroaxis
few days ago at news.google.com         
ProPhase Labs Inc. stock retracement recovery analysis - Trade Analysis Summary Target Return Focuse...
Google News at Macroaxis
few days ago at globenewswire.com         
ProPhase Labs to Present at the 2025 ThinkEquity Conference
Macroaxis News: globenewswire.com
over a week ago at finance.yahoo.com         
ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clin...
Yahoo News
over a week ago at thefly.com         
ProPhase Labs announces study validating BE-Smart cancer test PRPH
news
over a week ago at thefly.com         
ProPhase Labs files to sell 226.31M shares of common stock for holders PRPH
news
over a week ago at seekingalpha.com         
ProPhase Labs files to sell 226.31M shares of common stock for holders
seekingalpha News
over a week ago at news.google.com         
ProPhase Labs Inc. stock retracement recovery analysis - Trade Risk Summary Technical Pattern Alert ...
Google News at Macroaxis
over a week ago at news.google.com         
How ProPhase Labs Inc. stock reacts to global recession fears - Market Activity Report Technical Con...
Google News at Macroaxis
over two weeks ago at news.google.com         
Prophase Labs enters into sales agreement with WestPark Capital relating to shares - MarketScreener
Google News at Macroaxis
over two weeks ago at news.google.com         
What analyst consensus says on ProPhase Labs Inc. stock - Trade Volume Report Daily Market Momentum ...
Google News at Macroaxis
There is far too much social signal, news, headlines, and media speculation about ProPhase Labs that are available to investors today. This information is accessible both publicly - through ProPhase Labs' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of ProPhase-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of ProPhase Labs news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ProPhase Labs relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ProPhase Labs' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ProPhase Labs alpha.

ProPhase Labs Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment
08/12/2025
2
Acquisition by Ted Karkus of 500000 shares of ProPhase Labs at 0.6 subject to Rule 16b-3
09/09/2025
3
Volume Recap Will ProPhase Labs Inc benefit from government policy - July 2025 Update AI Enhanced Execution Alerts -
09/15/2025
4
ProPhase Labs continues exploration of crypto treasury strategy PRPH
09/22/2025
5
ProPhase announces three COVID-19 testing companies filed for reorganization PRPH
09/23/2025
6
What analyst consensus says on ProPhase Labs Inc. stock - Weekly Risk Summary Community Verified Trade Signals - newser.com
09/29/2025
7
ProPhase Labs Inc. stock outlook for YEAR - Analyst Upgrade Weekly Watchlist of Top Performers - newser.com
10/02/2025
8
Prophase Labs enters into sales agreement with WestPark Capital relating to shares - MarketScreener
10/15/2025
9
ProPhase Labs files to sell 226.31M shares of common stock for holders
10/21/2025
10
ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology
10/22/2025
11
ProPhase Labs announces publication of BE-Smart Esophageal Cancer study PRPH
10/29/2025

Complementary Tools for ProPhase Stock analysis

When running ProPhase Labs' price analysis, check to measure ProPhase Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProPhase Labs is operating at the current time. Most of ProPhase Labs' value examination focuses on studying past and present price action to predict the probability of ProPhase Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProPhase Labs' price. Additionally, you may evaluate how the addition of ProPhase Labs to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Transaction History
View history of all your transactions and understand their impact on performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios